PCI Biotech Holding ASA
OSE:PCIB
PCI Biotech Holding ASA
OSE:PCIB
Price:
0.1805
NOK
-5.74%
Market Cap:
kr6.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
PCI Biotech Holding ASA
OSE:PCIB
|
NO |
|
D
|
DeA Capital SpA
F:CWH
|
IT |
|
Midatech Pharma PLC
LSE:MTPH
|
UK |
|
V
|
Vikas Ecotech Ltd
BSE:530961
|
IN |
|
QITIAN Technology Group Co Ltd
SZSE:300061
|
CN |
|
J
|
JATT Acquisition Corp
F:1GU
|
KY |
|
Crown Point Energy Inc
XTSX:CWV
|
CA |
|
Evelo Biosciences Inc
OTC:EVLO
|
US |
|
Oppenheimer Holdings Inc
NYSE:OPY
|
US |
|
U
|
Ugar Sugar Works Ltd
NSE:UGARSUGAR
|
IN |
|
Trelleborg AB
STO:TREL B
|
SE |
|
Medirom Healthcare Technologies Inc
NASDAQ:MRM
|
JP |
|
A
|
Agro Phos India Ltd
NSE:AGROPHOS
|
IN |
|
S
|
Shijihengtong Technology Co Ltd
SZSE:301428
|
CN |
|
C
|
Cofle SpA
MIL:CFL
|
IT |
|
A
|
Aju IB Investment Co Ltd
KOSDAQ:027360
|
KR |
|
D
|
Dexelance SpA
MIL:DEX
|
IT |
|
W
|
Wikana SA
WSE:WIK
|
PL |
|
Pintec Technology Holdings Ltd
NASDAQ:PT
|
CN |
|
Seven Principles AG
XETRA:T3T1
|
DE |
|
Beijing Jiaoda Singal Technology Co Ltd
SZSE:300851
|
CN |
|
Beijer Alma AB
STO:BEIA B
|
SE |
|
A
|
AVIC Electromechanical Systems Co Ltd
SZSE:002013
|
CN |
Balance Sheet
Balance Sheet Decomposition
PCI Biotech Holding ASA
PCI Biotech Holding ASA
Balance Sheet Decomposition is not available for
PCI Biotech Holding ASA
PCI Biotech Holding ASA
Balance Sheet
PCI Biotech Holding ASA
PCI Biotech Holding ASA
Currency: NOK
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
1
|
50
|
36
|
111
|
95
|
73
|
47
|
16
|
49
|
14
|
51
|
349
|
261
|
188
|
116
|
57
|
41
|
27
|
|
| Cash Equivalents |
1
|
50
|
36
|
111
|
95
|
73
|
47
|
16
|
49
|
14
|
51
|
349
|
261
|
188
|
116
|
57
|
41
|
27
|
|
| Total Receivables |
0
|
4
|
6
|
4
|
5
|
5
|
6
|
5
|
7
|
8
|
8
|
8
|
15
|
13
|
12
|
6
|
3
|
4
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
|
| Other Receivables |
0
|
4
|
5
|
4
|
5
|
5
|
6
|
5
|
0
|
0
|
8
|
8
|
15
|
13
|
12
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
54
|
41
|
115
|
100
|
78
|
53
|
20
|
56
|
22
|
58
|
357
|
276
|
201
|
128
|
63
|
44
|
31
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
8
|
8
|
1
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
8
|
8
|
1
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
6
|
12
|
13
|
13
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
55
+5 360%
|
42
-24%
|
115
+176%
|
100
-12%
|
78
-22%
|
53
-33%
|
20
-61%
|
56
+177%
|
22
-60%
|
58
+161%
|
357
+511%
|
282
-21%
|
209
-26%
|
136
-35%
|
63
-53%
|
44
-31%
|
31
-29%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
0
|
3
|
3
|
2
|
2
|
2
|
4
|
3
|
3
|
2
|
1
|
2
|
9
|
5
|
4
|
0
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
11
|
12
|
14
|
3
|
3
|
0
|
|
| Short-Term Debt |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
2
|
3
|
4
|
3
|
4
|
4
|
8
|
9
|
7
|
13
|
2
|
5
|
2
|
2
|
1
|
1
|
6
|
|
| Total Current Liabilities |
0
|
5
|
7
|
7
|
6
|
8
|
9
|
11
|
12
|
9
|
15
|
17
|
25
|
20
|
21
|
6
|
5
|
8
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
2
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
5
N/A
|
7
+23%
|
9
+40%
|
8
-16%
|
9
+12%
|
9
+9%
|
11
+21%
|
12
+8%
|
9
-23%
|
17
+78%
|
17
+3%
|
27
+59%
|
20
-27%
|
22
+12%
|
6
-73%
|
5
-18%
|
8
+55%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
1
|
16
|
16
|
23
|
23
|
23
|
23
|
23
|
45
|
45
|
75
|
111
|
112
|
112
|
112
|
112
|
1
|
1
|
|
| Retained Earnings |
0
|
88
|
0
|
85
|
99
|
124
|
57
|
91
|
121
|
152
|
190
|
221
|
307
|
373
|
449
|
55
|
0
|
22
|
|
| Additional Paid In Capital |
0
|
0
|
90
|
168
|
168
|
77
|
77
|
77
|
121
|
121
|
157
|
449
|
450
|
450
|
450
|
0
|
38
|
0
|
|
| Other Equity |
0
|
55
|
71
|
0
|
0
|
94
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
49
+4 830%
|
35
-29%
|
105
+200%
|
93
-12%
|
70
-25%
|
43
-38%
|
9
-79%
|
44
+386%
|
13
-70%
|
42
+220%
|
340
+712%
|
255
-25%
|
189
-26%
|
114
-40%
|
57
-50%
|
39
-32%
|
23
-40%
|
|
| Total Liabilities & Equity |
1
N/A
|
55
+5 360%
|
42
-24%
|
115
+176%
|
100
-12%
|
78
-22%
|
53
-33%
|
20
-61%
|
56
+177%
|
22
-60%
|
58
+161%
|
357
+511%
|
282
-21%
|
209
-26%
|
136
-35%
|
63
-53%
|
44
-31%
|
31
-29%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
10
|
10
|
10
|
13
|
13
|
13
|
13
|
13
|
21
|
16
|
27
|
37
|
37
|
37
|
37
|
37
|
37
|
37
|
|
Switch to:
Switch to:
See Also
Discover More
